Skip to content

Clinical trials

Phase 3 Prostatic Neoplasms trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 3 Country / region: Brazil Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20073
20084
20092
20102
20114
20132
20143
20153
20172
20181
20194
20205
20211
20222
20232
20241
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting16
Recruiting7
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca9
Merck Sharp & Dohme LLC5
Pfizer5
Sanofi5
Bristol-Myers Squibb4
Aragon Pharmaceuticals, Inc.3
Janssen Research & Development, LLC3
Bayer2
Novartis Pharmaceuticals2
Active Biotech AB1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms51
Neoplasm Metastasis4
Neoplasms3
Breast Neoplasms1
Bulbo-Spinal Atrophy, X-Linked1
Recurrence1
Urogenital Neoplasms1

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.